Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Welgene Biotech

2003 FOUNDED
PUBLIC STATUS
71-80 EMPLOYEES
6661 STOCK SYMBOL
$0.82 SHARE PRICE (As of Thursday Closing)
Description

Provider of laboratory services. The company's business includes stable gene-related research technology and is dedicated to applying the results of scientific research to clinical tests.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Laboratory Services (Healthcare)
Stock Exchange
ROCO
Primary Office
  • Nangang District 3
  • Park Street 12th Floor
  • Taipei, 115-03
  • Taiwan

+886 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Welgene Biotech’s full profile, request a free trial.

Welgene Biotech Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.66 - $0.99 $15.7M $0.82 $0.04 72.1K 19.2M

Welgene Biotech Financials Summary

In Thousands,
USD
TTM
31-Dec-2017
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 10,547 10,547
Revenue 10,686 10,686 8,589 8,676
EBITDA 1,204 1,204 452 941
Net Income 776 776 126 666
Total Assets 10,511 10,511 8,502 8,324
Total Debt 1,045 1,045 727 958
Public Fundamental Data provided by Morningstar, Inc. disclaimer